We see innovations and inventions in biotechnology and cutting-edge R&D in stem cell research. But there have been very few evolutions when it comes to medical care for pets as much as you would expect. ABC’s ‘Shark Tank’ provides a platform for innovators to present such unique concepts. In Season 11, episode 8, startup entrepreneur Aaron Hirschhorn introduced us to stem cell banking solutions for dogs.
While there might have been researches and there are a few clinics around the United States who allow pet owners to store their pooches’ stem cells, no one has taken it to the level of turning it into a million-dollar worth business. Hirschhorn started ‘Gallant’ with the aim of helping dogs heal and be treated the same way as we humans have the privilege now.
The idea stemmed from his personal experience when he watched his dog suffer from arthritis and it was unable to walk. Earlier, Hirschhorn had also founded ‘DogVacay’, a pet exchange program and dog sitting service. Extending his love for canines, combined with his experience, ‘Gallant’ turned out to be a novel idea, not only within the pet-owner fraternity but also among biotechnologists.
The animal biotech startup creates cell therapy products derived from reproductive tissues, at the time of spaying and neutering the dog. The patent-pending process is non-invasive and has already created quite the buzz and vets are already looking forward to rapid growth in this field of medical research. When…